developed MRI radiomics models using multiparametric MRI sequences to differentiate HER2‐zero from HER2‐low/positive cancers, with an AUC of 0.80 in the external test set.[25] Similarly, Chen et al. This evidence concerns the gene ERBB2 and cancer.